Resources

Drabiak’s Articles

 

Drabiak, Expanding Medication Assisted Treatment is Not the Answer: Flaws in the Substance Abuse Treatment Paradigm, under review for publication.

Drabiak, Roundup Litigation: Using Discovery to Dissolve Doubt, under review for publication.

Drabiak, Untangling the Promises of Human Genome Editing, Journal of Law, Medicine & Ethics, forthcoming Fall 2018.

Drabiak, Emerging Governance of Mitochondrial Replacement Therapy: Assessing Coherence Between Scientific Evidence and Policy Outcomes, 20(1) Journal of Health Care Law 1-61(2018).

Drabiak, Dying to Be Fresh and Clean? Assessing Regulatory Shortcomings  Governing Personal Care Products, Cancer Risk, and Epigenetic Damage, 35 Pace Environmental Law Review 75-107 (2018).

Drabiak, The Impact of a Developing Regulatory Framework Governing LDTs in Precision Oncology: Re-envisioning the Clinical Risk Assessment Paradigm,   13 Journal of Health &  Biomedical Law 1-57 (2017).

Drabiak, Caveat Emptor: How the Intersection of Big Data and Consumer Genomics Exponentially Increases Informational Privacy Risks, 27 Health Matrix: Journal of Law-Medicine 153-184 (2017).

Drabiak, Challenging FDA’s Authority to Regulate Autologous Adult Stem Cells for Therapeutic Use: Celltex, Substantial Risks, and the Implications of US v. Regenerative Sciences, 23 Health Matrix: Journal of Law-Medicine, 493-535 (2013).

 Drabiak, New President, New hESC Research Policy:  Comparative International Perspectives and Embryonic Stem Cell Research Laws in France,  32 Biotechnology and Pharmaceutical Law Review 349-356 (2013).

Drabiak, Granular Control of EHRs to Overcome Fragmented Disclosure Law: How Policy Choices for  Granularity will Affect Clinical Care, Impact Secondary Use of Health Information, and Alter Risks for Patients and Providers, 10 Indiana Health Law Review 39-73 (2013).

 Drabiak, Sleep Deprived Physicians Considering Modafinil: Using a Controlled Substance For Cognitive Enhancement Gambles With Differential Drug Responses and Violates Ethical And Legal Duties Against Physician Impairment, 13 Journal of Health Care Law 339-366 (2011).

Drabiak, Waiving Informed Consent to Prenatal Screening and Diagnosis? Problems with Paradoxical Negotiation in Surrogacy Contracts, Currents in Contemporary Ethics,  39 Journal of Law, Medicine & Ethics 559-564 (2011).

Drabiak, Reining In The Pharmacological Enhancement Train: We Should Remain Vigilant About Regulatory Standards For Prescribing Controlled Substances, 39 Journal of Law, Medicine & Ethics 272-279 (2011).

Drabiak, Physicians Prescribing “Medicine” for Enhancement: Why We Should Not and Cannot Overlook Safety Concerns, Open Peer Commentary, 11 American Journal of Bioethics 17-19 (2011).

Drabiak, Lessons from Havasupai Tribe v. Arizona State University Board of Regents: Recognizing Group, Cultural, and Dignitary Harms as Legitimate Risks Warranting Integration into Research Practice, 6 Journal of Health & Biomedical Law 175-225 (2010).

 Drabiak, Legal Regulation of Banking Newborn Blood Spots for Research: How Bearder and Beleno Resolve the Question of Consent, 11 Houston Journal of Health Law & Policy 1-46 (2010).

Drabiak, Baby Gender Mentor: Class Action Litigation Calls Attention to a Deficient Federal Regulatory Framework for DTC Genetic Tests, Politicized State Statutory Construction, and a Lack of Informed Consent, 14 Michigan State University Journal of Medicine and Law 71-92 (2010).

Drabiak, Revisiting the USPTO’s Examination Guidelines for Gene Patents: Congressional Inaction, USPTO Restraint, and Judicial Remedy, 6 Journal of International Biotechnology Law 204-209 (2009).

Drabiak, State Codification of Federal Regulatory Ambiguities in Biobanking and Genetic Research: What Can We Learn from New Mexico and Minnesota?, 30 Journal of Legal Medicine 299-327 (2009).

Girod & Drabiak, A Proposal for Comprehensive Biobank Research Laws to Promote Translational Medicine in Indiana, 5 Indiana Health Law Review 217-250 (2008).

Morrell, Brown, Qi, Drabiak, Helft, The Do-Not-Resuscitate Order: Association with Advance Directives, Physician Specialty, and Documentation of Discussion 15 Years After the PSDA, 34 Journal of Medical Ethics 642-647 (2008).

Haas, Renbarger, Meslin, Drabiak, Flockhart, Patient Attitudes Toward Genotyping in an Urban Women’s Health Clinic, 112 Obstetrics and Gynecology 1023-1028 (2008).

Drabiak et al.,  Ethics, Law, and Commercial Surrogacy: A Call for Uniformity, 35 Journal of Law, Medicine & Ethics 300-309 (2007).

 

Websites and Blogs of Interest:

 

 Bioethics and Genomics

 

American Journal of Bioethics Blog
http://www.bioethics.net

Center for Genetics and Society Biopolitcal Times
http://www.biopoliticaltimes.org/article.php?list=class&class=20&qty=4

Bioedge
http://www.bioedge.org

The Hasting Center for Bioethics Forum
http://www.thehastingscenter.org/BioethicsForum/Default.aspx

 

 

Health Law

 

Robinson Bradshaw & Hinson’s Genomics Law Report
http://www.genomicslawreport.com

 

 

Functional Medicine

 

Kelly Brogan, MD.  Holistic Women’s Health Psychiatrist.  http://kellybroganmd.com

Sara Gottfried, MD.  Integrative Physician for Women. http://www.saragottfriedmd.com

Mark Hyman, MD.  Integrative Physician.  http://drhyman.com

Judith Orloff, MD.  Integrative Psychiatrist.  http://www.drjudithorloff.com

David Perlmutter, MD.  Integrative Neurologist.  http://www.drperlmutter.com

Aviva Romm, MD.  Integrative Physician for Women and Children.  http://avivaromm.com

Andrew Weil, MD.  Integrative Physician.  http://www.drweil.com

GreenMedInfo. http://www.greenmedinfo.com